Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Wednesday, September 26, 2012

FDA Antibiotics Task Force!

›
The FDA recently announced the formation of a new task force to support innovation in antibacterial drug development.   I ...
Wednesday, September 12, 2012

Antibiotics, ICAAC and Bronchitis

›
I am writing this blog on the last day of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Fran...
Tuesday, September 4, 2012

New Antibiotics? Go Public!

›
I am now contemplating a talk I have to give at ICAAC this year (Intersciences Conference on Antimicrobial Agents and Chemotherapy...
Tuesday, August 28, 2012

Antibiotics in the News

›
The NIH recently reported   an outbreak at the NIH hospitals where 11 patients died with infection caused by a KPC carbape...
1 comment:
Wednesday, August 22, 2012

Fluoroquinolones - More Toxic than Ketek?

›
An article just published in the Canadian Medical Association Journal suggests that, at least among patients older than 65 years of age,...
2 comments:
Sunday, August 12, 2012

Rebooting Hospital Acquired Pneumonia at FDA.

›
As I mentioned in my last blog , I was recently invited to participate in another meeting with the FDA at the Brookings Institution.   A...
Tuesday, July 31, 2012

Rebooting Pneumonia at the FDA

›
I was recently invited to participate in another meeting with the FDA at the Brookings Institution.   At the last meeting (summa...
1 comment:
‹
›
Home
View web version
Powered by Blogger.